Matthew Meriggioli to Insulin-Like Growth Factor I
This is a "connection" page, showing publications Matthew Meriggioli has written about Insulin-Like Growth Factor I.
Connection Strength
0.183
-
Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial. Lancet Neurol. 2018 12; 17(12):1043-1052.
Score: 0.148
-
Circulating levels of IGF-I in patients with chronic uremia on conservative dietary treatment. Ren Fail. 1998 Mar; 20(2):357-60.
Score: 0.035